NVAX Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: Potential FDA approval may drive the stock up as Novavax leverages its unique protein-based technology and global market expansion, backed by high call volume.




Bearish Case: Regulatory hurdles and intense competition may hinder recovery, keeping prices low and causing more volatility despite Novavax's technological advancements.




Potential Outcomes:
  1. FDA approval boosts NVAX 40%.
  2. Regulatory delays persist 35%.
  3. Market skepticism impacts growth 15%.
  4. Unexpected events sway prices 10%.



May 13, 2025


Novavax Forecast

NVAX        Novavax











Correlated Assets

Assets that tend to move strongly with NVAX



XRX Forecast + Options Trading Strategies   XRX  Xerox (0.94)


STNG Forecast + Options Trading Strategies   STNG  Scorpio Tankers (0.92)


VAL Forecast + Options Trading Strategies   VAL  Valaris (0.92)


ADM Forecast + Options Trading Strategies   ADM  Archer Daniels Midland (0.9)


FSLR Forecast + Options Trading Strategies   FSLR  First Solar (0.87)



Uncorrelated Assets

Assets with little price relationship to NVAX



ATHM Forecast + Options Trading Strategies   ATHM  Autohome (-0.01)


ETR Forecast + Options Trading Strategies   ETR  Entergy (-0.01)


WCC Forecast + Options Trading Strategies   WCC  Wesco International (0.02)


FE Forecast + Options Trading Strategies   FE  Firstenergy (0.02)


RMBS Forecast + Options Trading Strategies   RMBS  Rambus (-0.02)



Anticorrelated Assets

Assets that tend to move strongly against NVAX



LNG Forecast + Options Trading Strategies   LNG  Cheniere Energy (-0.75)


IMAX Forecast + Options Trading Strategies   IMAX  Imax (-0.77)


LRN Forecast + Options Trading Strategies   LRN  Stride (-0.78)


TW Forecast + Options Trading Strategies   TW  Tradeweb Markets (-0.78)


JPM Forecast + Options Trading Strategies   JPM  JPMorgan Chase (-0.79)









Become a more profitable investor with AI optimized trading strategies






×

Chat with NVAX


 Ask any question about NVAX!